Vivos

Dental Sleep: Vivos

One in Four Patients in Latest Clinical Study Show No Symptoms of Obstructive Sleep Apnea After Vivos Treatment

HIGHLANDS RANCH, Colo., July 13, 2021 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment […]

One in Four Patients in Latest Clinical Study Show No Symptoms of Obstructive Sleep Apnea After Vivos Treatment Read More »

Vivos Therapeutics’ powerful online education and training program sees surge in demand from over 4,300 dental and medical professionals

  DENVER, April 17, 2020 (Newswire.com) – ​​​​​​​Vivos Therapeutics, Inc., a company focused on addressing the root causes of mild-to-moderate obstructive sleep apnea (OSA), recently launched, and has seen a significant

Vivos Therapeutics’ powerful online education and training program sees surge in demand from over 4,300 dental and medical professionals Read More »

Shopping Cart
Scroll to Top